Form 4/A for LNAI Lunai Bioworks Inc.
Accepted 2024-08-16 00:00:00 ET · period of report 2024-08-12 · accession 0001213900-24-070297 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| AI | 2024-08-16 | 2024-08-12 | LNAI | Brink Karen | Dir, 10% | J - Other | — | +2.00M | 25.37M | +9% | — |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-08-12 | J | A | 2,000,000 | — | 25,372,969 | I By Yalla Yalla Ltd. | — | — | (F1) This Form 4/A is filed to amend the original Form 4 filed by the reporting person on August 13, 2024, which incorrectly reported the transfer of the common shares. The common shares reported on this Form 4/A were not transferred by Yalla Yalla Ltd. ("Yalla Yalla") to an entity pursuant to a consulting agreement dated August 5, 2024, as payment for certain services rendered to Yalla Yalla. (F2) The Reporting Person, as ultimate beneficial owner of Yalla Yalla, beneficially owns the securities reported in Column 5 indirectly, but disclaims beneficial ownership of the reported securities except to the extent of its pecuniary interest therein. |